These findings underscore the important connection between JAK2 mutations, inflammasome activation, oxidative damage, and atherosclerosis, suggesting potential therapeutic avenues for managing CHIP-related cardiovascular risk. The gene discussed is STUB1; the disease is atherosclerosis.